01 November 2021 – Rent the Runway Lands $357m in IPO

Rent the Runway lands $357m in IPO

US-based fashion rental service Rent the Runway – which operates an online platform that allows customers to rent high-fashion items through a subscription service – has gone public on the Nasdaq Select Market in a $357m IPO, which marks an exit for existing backers media group Advance Publications and payment services firm American Express.

Xilio Therapeutics tunes into $118m IPO

Xilio Therapeutics, a US-based cancer immunotherapy developer backed by pharmaceutical firms Takeda, Merck & Co, Ipsen and Merck Group, floated on Friday in an initial public offering sized at almost $118m.

Nubank looks to cash in IPO

Nu Holdings, the holding entity for Brazil-based digital bank operator Nubank, announced that it had confidentially filed a draft registration for an IPO. The IPO would mark an exit for internet and gaming group Tencent and Warren Buffet’s Berkshire Hathaway,

Fluence flies on to Nasdaq in $868m IPO

Fluence, the Germany-based energy storage system provider launched by industrial equipment producer Siemens and electric utility AES, floated the Nasdaq Global Market in an $868m initial public offering.

Truepill swallows $142m in series D round

US-based patient engagement software provider Truepill, which is backed by healthcare provider Optum, closed its series D round at $142m, provided by Investment advisory firm TI Platform Management and Initialized Capital.

DNA Script prints $165m series C details

France-based synthetic DNA producer DNA Script secured $165m in a series C round featuring corporates Merck Group, Illumina, Danaher and Agilent Technologies.

Medable moves to next stage with $304m

Medable, a US-based developer of clinical trials management software – whose cloud-based software allows researchers to carry out decentralised trials complete with remote design, evaluation and management solutions – raised $304m in series D funding at a $2.1bn valuation.

Immunai imports $215m in series B funding

Koch Disruptive Technologies, a corporate venturing subsidiary of chemicals and energy conglomerate Koch Industries, led a $215m series B round for US-based cancer therapy database developer Immunai.

Swiss Re backs Paytm Insurtech

Reinsurance provider SwissRe has agreed to invest the equivalent of $123m in India-based digital financial services provider Paytm’s insurance arm, Paytm Insurtech.

Acko attracts $255m in series D funding

India-based online insurance platform Acko has raised $255m in a series D round featuring insurance providers Munich Re and Intact Financial at a valuation of $1.1bn

Exelon to escort diverse founders to $36m fund

US-based electric, gas and nuclear utility Exelon formed a $36m investment vehicle dubbed Racial Equity Capital Fund in a bid to back minority-owned companies.

SoftBank uncovers second China-focused fund

Telecommunications and internet conglomerate SoftBank’s SoftBank Ventures Asia arm has formed a second China-focused vehicle.

Investors serve Bread and Butter Ventures with $27m

US-based venture capital firm Bread and Butter Ventures launched a $27m third fund on Tuesday featuring limited partners including logistics group Atco, brewery Bernick’s and carmaker Toyota’s CVC Toyota Ventures.

Ecosia collates $405m World Fund

Germany-based ecologically-minded search engine operator Ecosia formed a venture capital vehicle dubbed World Fund, with a $405m targeted close, aimed at supporting entrepreneurs working to tackle climate change.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

Leave a Reply

Your email address will not be published. Required fields are marked *